Title
Description
This is a flow chart showing the progress from NDA/BLA to NDA/BLA Review to Approval to Launch. It includes sections for Strategic Development Medical and Clinical Planning/Forecasting and Promotion. Each section is color-coded with comment bubbles (throughout) in white.
Type 
Category
-
Date
None
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
![A screenshot of the Formulary update page of the XARTEMIS XR (oxycodone HCI and acetaminophen Extended-Release Tablets (CII) website. The page has a white background with a yellow header and footer. The header reads "Formulary update" in bold black font. Below the header there is a text box with the text "XARTEMIS XR is available unrestricted on [tier #1] for [Plan Name] Commercial Patients. No PA/step therapy requirement. Patients will have an average co-pay of $1". <br /><br />At the bottom of the page there are two buttons - "FORMULARY UPDATE" and "FORMULAR UPDATE". The first button is for the user to click on the "formulary update" button and the second button is to view additional information about the product.<br /><br />On the right side of the image the page has the logo of the website which is a purple and white shield with the company's name and contact information. At the top right corner the time and date of the update is 11:27 AM.](https://oida-resources-images.azureedge.net/public/full/06af7f03-9e0c-4f16-8a36-e3a2e5d38325.png)
